Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage II-III Non-small Cell Lung Cancer”

449 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 449 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07318883
What this trial is testing

A Phase II/III Clinical Study to Evaluate HLX07 in Combination With Serplulimab and Chemotherapy Versus Placebo in Combination With Serplulimab or Pembrolizumab and Chemotherapy as First-Line Treatment in Advanced Squamous Non-Small Cell Lung Cancer

Who this might be right for
Squamous NSCLC
Shanghai Henlius Biotech 720
Not applicableStudy completedNCT00002520
What this trial is testing

Physician-Initiated Stop-Smoking Program for Patients Receiving Treatment for Early-Stage Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Eastern Cooperative Oncology Group 434
Large-scale testing (Phase 3)Study completedNCT00002823
What this trial is testing

Combination Chemotherapy Compared With No Treatment Following Surgery in Treating Patients With Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris 3,300
Testing effectiveness (Phase 2)Looking for participantsNCT07410975
What this trial is testing

Efficacy of Anti-CTLA-4 Antibody Combined With Sintilimab and Chemotherapy as Neoadjuvant Therapy for Resectable Stage II-III Non-Small Cell Lung Cancer

Who this might be right for
NSCLC Stage IINSCLC Stage III
Shanghai Pulmonary Hospital, Shanghai, China 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06585644
What this trial is testing

A Clinical Trial of Furmonertinib Combination Therapy As Neoadjuvant Treatment in Resectable EGFR-Mutated NSCLC

Who this might be right for
Lung Cancer (NSCLC)
Shanghai Pulmonary Hospital, Shanghai, China 44
Not applicableStudy completedNCT01837511
What this trial is testing

Analysis of the Incidence of Expression of Tumor Antigens in Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer(NSCLC) in Asiatic Patients

Who this might be right for
Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer (NSCLC)
GlaxoSmithKline 377
Testing effectiveness (Phase 2)Study completedNCT00002475
What this trial is testing

Cyclophosphamide Plus Vaccine Therapy in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerColorectal CancerKidney Cancer+3 more
St. Vincent Medical Center - Los Angeles 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT02864992
What this trial is testing

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

Who this might be right for
Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET AmplificationLung Adenocarcinoma Stage IIIB/IV
EMD Serono Research & Development Institute, Inc. 337
Testing effectiveness (Phase 2)Active Not RecruitingNCT07632365
What this trial is testing

Induction Chemoimmunotherapy in Combination With Chemoradiotherapy and Consolidation Immunotherapy in Unresectable Locally Advanced Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerLocally Advanced Non-Small Cell Lung CancerUnresectable Stage III NSCLC
Shanghai Chest Hospital 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT06319313
What this trial is testing

Efficacy and Safety of JMT101 Combined Wth Docetaxel / HB1801 in Patients With Squamous Cell Non-Small Cell Lung Cancer

Who this might be right for
Squamous Cell Non-small Cell Lung Cancer
Shanghai JMT-Bio Inc. 534
Large-scale testing (Phase 3)Study completedNCT04385368
What this trial is testing

Phase III Study to Determine the Efficacy of Durvalumab in Combination With Chemotherapy in Completely Resected Stage II-III Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 89
Testing effectiveness (Phase 2)Ended earlyNCT00618917
What this trial is testing

MnSOD (Esophageal Protectant) to Prevent Esophagitis During Radiation/Chemotherapy Treatment for Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
EsophagealToxicity
Joel Greenberger 18
Large-scale testing (Phase 3)UnknownNCT03732482
What this trial is testing

Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain Metastases

Who this might be right for
Non Small Cell Lung Cancer Metastatic
Taizhou Hospital 400
Large-scale testing (Phase 3)UnknownNCT02029209
What this trial is testing

To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 110
Testing effectiveness (Phase 2)Looking for participantsNCT05398094
What this trial is testing

Clinical Trial of AMG510 in Stage III Unresectable NSCLC KRAS p.G12C Patients and Ineligible for Chemo-radiotherapy

Who this might be right for
Non-small Cell Lung Cancer Stage IIIKRAS P.G12C
Fundación GECP 19
Testing effectiveness (Phase 2)Study completedNCT00103051
What this trial is testing

Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Large-scale testing (Phase 3)Study completedNCT01905657
What this trial is testing

Study of Two Doses of Pembrolizumab (MK-3475) Versus Docetaxel in Previously Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)

Who this might be right for
Non Small Cell Lung Cancer (NSCLC)
Merck Sharp & Dohme LLC 1,034
Large-scale testing (Phase 3)Active Not RecruitingNCT03800134
What this trial is testing

Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung Cancer
AstraZeneca 825
Large-scale testing (Phase 3)Active Not RecruitingNCT05020769
What this trial is testing

SI-B001 Combined With Osimertinib Mesylate Tablets in the Treatment of Recurrent Metastatic Non-small Cell Lung Cancer.

Who this might be right for
Non-small Cell Lung Cancer
Sichuan Baili Pharmaceutical Co., Ltd. 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07561983
What this trial is testing

Tislelizumab Plus Chemotherapy and BACE for Unresectable NSCLC

Who this might be right for
Unresectable Stage III Non-small Cell Lung CancerTislelizumabChemotherapy+2 more
Sichuan Cancer Hospital and Research Institute 39
Load More Results